SavedAdd your journal

Journals / Haydarpaşa Numune Eğitim ve Araştırma Hastanesi Tıp Dergisi / 2005 / Cilt: 45 - Sayı: 3

Efficacy of ropivacaine v.s. bupivacaine on axillar branchial block

Aksiler brakiyal pleksus bloğunda bupivakain ve ropivakainin etkinliğinin karşılaştırılması

Göksu Şenay TOMRUK
Neşe AYDIN
Osman EKİNCİ
Pages
155–157
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Onset time, sensorial and motor block qualities, adverse effects were recorded. p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Efficacy of Ropivacaine v.s.
📊
Key Findings & Data:After the Ethics Committee and patient approvals, 30 patients (ASA l-ll, aged 18 to 65 years, undergo tenoraphy) were enrol¬led in this study. 0.08 mg/kg diazepam and 0.5 mg atropine were used as premedication .
💡
Conclusion & Impact:Onset time, sensorial and motor block qualities, adverse effects were recorded. p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Efficacy of Ropivacaine v.s. Bupivacaine on Axillar Brachial Block It has been reported that; toxic effects of ropivacain are less than and onset time is shorter than bupivacaine. This study was designed as prospective, randomize, unicentral. The aim of this study was to compare onset time and duration of action, sensorial and motor block qualities and adverse effects of ropivacaine with bupivacaine on axillar blockage. After the Ethics Committee and patient approvals, 30 patients (ASA l-ll, aged 18 to 65 years, undergo tenoraphy) were enrol¬led in this study. 0.08 mg/kg diazepam and 0.5 mg atropine were used as premedication . We divided patients randomly in 2 groups, with using peripheral nerve stimulator; in the 1st group 2.5 mg/kg bupivacaine in 40 cc 0.9% NaCI solution, in the 2nd group 2.5 mg/kg ropivacaine in 40 cc 0.9% cc NaCI solution were performed. Onset time, sensorial and motor block qualities, adverse effects were recorded. p

Özet

Ropivakainin toksik etkilerinin, bupivakainden daha az, etki başlama süresinin daha kısa olduğu bildirilmektedir. Prospektif, randomize tek merkezli olarak planla¬nan çalışmamızda ropivakainin aksiler brakiyal pleksus blok uygulamasında etki başlama süresini, etki süresini, sensoryal ve motor blok kalitesini, yan etkilerini bupiva-kainle karşılaştırmayı amaçladık. Etik kurul ve hasta onayı alınarak, ASA l-ll, 18-65 yaş arası, tendon onarımı planlanan 30 hasta çalışmaya alındı. Premedikasyonda 0.08 mg/kg diazem, 0.5 mg atropin kullanıldı. Hastalar iki gruba ayrıldı. Periferik sinir sitimulatörü kullanılarak; I. gruba 2.5 mg/kg bupivakain 40 ml SF içinde, II.gruba 2.5 mg/kg ropivakain 40 mi SF içinde uygulandı. Etki başlama süresi, duyusal ve motor blok kalitesi, yan etkileri kaydedildi. p

🔖

Cite This Article

TOMRUK, G. Ş., AYDIN, N., EKİNCİ, O. (2022). Efficacy of ropivacaine v.s. bupivacaine on axillar branchial block. Haydarpaşa Numune Eğitim ve Araştırma Hastanesi Tıp Dergisi, Cilt: 45 - Sayı: 3, 155–157. https://ajindex.com/articles/535636

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (17)

  1. Morgan GE Jr, M D: Clinical Anesthesiology. Third edition. California; 2002:249-56
  2. Kayhan Z Klinik Anestezi. Logos Yayıncılık, Ankara, 1997;457-77
  3. Berde CB, Stricharte GR. Local anesthetics. In: Miller RD. Anesthesia. 5th edition. 2000:491-521
  4. D'alessio J et al. A retrospective comparison of interscalene block and general anaesthesia for ambulatory surgery shoulder arthroscopy. Reg Anesth 1995;20:62-8
  5. Raeder JC, Drosdahl S et al. Axillary brachial plexus block with ropivacaine 7.5 mg/ml. Ada Anaesthesiol Scand 1999;43(8):714-98
  6. Calsati A, Fanalli G et al. A clinical comparison of ropivacaine 0.75%, ropivacaine 1% or bupivacaine 0.5% for interscalene brachial plexus. Eur J Anaesthesiol 1999;16(11):784-9
  7. Junca A, Marret E et al. A comparison of ropivacaine and bupivacaine for cervikal plexus block. Anesth Analg 2001;92:720-4
  8. Cirvan E, Barbieri S et al. Brachial plexus block with an innovative intrascalenic approach in the prosthetic surgery of the shoulder: use of ropivacaine versus bupivacaine; Medicominternational 1999;11:135
  9. Vainionpaa VA, Haavisto ET et al. A clinical and pharmacoki netic comparison of ropivacaine in axillary block. Anesth Analg 1995;81(3):539-538
  10. Me Glade DP, Kalpokas MVet al. A Comparison of 0.5% ropivacaine and 0.5% bupivacaine for axillary brachial plexus anaesthesia. Anaesth Intensive Care 1998;26(5):515-20
  11. Casati A, Fanelli G et al. Interscalene brachial plexus anasthesia with either 0.5% ropivacaine or 0.5% bupivacaine. Minerva Anesthesia 2000;66(1-2):39-44
  12. Leoni A, Maprin S et al. Cervikal plexus anesthesia for carotid endarterectomy: Comparison of ropivacaine and mepivacaine. Can J Anaesth 2000;47(2):185-7
  13. Pham-Dang C et al. A Novel Supraclavicular Approach to Brachial Plexus Block. Anest Analg 1997;85:111-6
  14. Hickey R, Hoffman J et al. A comparison of ropivacaine 0.5% and bupivacaine 0.5% for brachial plexus block. Anaesthesiology 1991;74:639-42
  15. Vaghadia H, Chan V et al. A multicentre trial of ropivacaine 7.5 mg/ml v.s bupivacaine 5 mg/ml for supraclavicular brachial plexus anesthesia. Can J Anaesth 1999;46(10):946-51
  16. Alsalti RA, el-Dawlatly AA et al. Arteriovenous fistula in chro nic renal failure patients; comparison between three different anesthetic techniques. Middle East J Anesthesiol 1999; 15(3):305-14
  17. Ekatodramis G et al. Continuous interscalane analgesia with ropivacaine 2 mg/ml after major shoulder surgery. Anesthesiology 2003;98:143-50